The role of inositol supplementation in patients with polycystic ovary syndrome, with insulin resistance, undergoing the low-dose gonadotropin ovulation induction regimen

Fertility and Sterility

Volumn 95, Issue 8, 2011, Pages 2642-2644

  Morgante, Giuseppe ^a   Orvieto, Raoul ^b,c   Di Sabatino, Alessandra ^a   Musacchio, Maria C ^a   De Leo, Vincenzo ^a  

^a UNIVERSITY OF SIENA   (Italy)

^b BARZILAI MEDICAL CENTER   (Israel)

^c BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

cancellation rate; gonadotropin; inositol; insulin resistance; ovulation induction; PCOS

Indexed keywords

BROMELAIN; CHORIONIC GONADOTROPIN; CLOMIFENE CITRATE; GONADOTROPIN; INOSITOL; LACTOFERRIN; METFORMIN; RECOMBINANT FOLLITROPIN; REDESTOP; UNCLASSIFIED DRUG;

ADD ON THERAPY; ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG POTENTIATION; FEMALE; HUMAN; INFERTILITY; INSULIN RESISTANCE; LONGITUDINAL STUDY; LOW DRUG DOSE; NUTRITIONAL SUPPORT; OVARY POLYCYSTIC DISEASE; OVULATION INDUCTION; PREGNANCY RATE; PRIORITY JOURNAL; PROSPECTIVE STUDY; TREATMENT OUTCOME;

ADULT; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; DIETARY SUPPLEMENTS; FEMALE; FERTILITY AGENTS, FEMALE; GONADOTROPINS; HUMANS; INFERTILITY, FEMALE; INOSITOL; INSULIN RESISTANCE; ITALY; LONGITUDINAL STUDIES; OVULATION; OVULATION INDUCTION; PILOT PROJECTS; POLYCYSTIC OVARY SYNDROME; PREGNANCY; PREGNANCY RATE; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 79956359964     PISSN: 00150282     EISSN: 15565653     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2011.01.035     Document Type: Article

References (24)

1. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome Fertil Steril 81 2004 19 25
2. I.F. Stein, and M.L. Leventhal Amenorrhea associated with bilateral polycystic ovaries Am J Obstet Gynecol 29 1935 181 191
3. A. Dunaif, M. Graf, J. Mandeli, V. Laumas, and A. Dobrjansky Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance, and/or hyperinsulinemia J Clin Endocrinol Metab 65 1987 499 507 (Pubitemid 17131438)
4. S. Robinson, D. Kiddy, S.V. Gelding, D. Willis, R. Niththyananthan, and A. Bush The relationship of insulin insensitivity to menstrual pattern in women with hyperandrogenism and polycystic ovaries Clin Endocrinol 39 1993 351 355 (Pubitemid 23274435)
5. S. Franks Genetic and environmental origins of obesity relevant to reproduction Reprod Biomed Online 12 2006 526 531 (Pubitemid 43674923)
6. A. Dunaif, K.R. Segal, W. Futterweit, and A. Dobrjansky Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome Diabetes 38 1989 1165 1174 (Pubitemid 19250404)
7. R. Homburg, R. Orvieto, I. Bar-Hava, and Z. Ben-Rafael Serum levels of insulin-like growth factor-1, IGF binding protein-1 and insulin and the response to human menopausal gonadotrophins in women with polycystic ovary syndrome Hum Reprod 11 1996 716 719 (Pubitemid 26142162)
8. O. Dale, T. Tanbo, E. Haug, and T. Abyholm The impact of insulin resistance on the outcome of ovulation induction with low-dose follicle stimulating hormone in women with polycystic ovary syndrome Hum Reprod 13 1998 567 570 (Pubitemid 28171947)
9. ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group Consensus on infertility treatment related to polycystic ovary syndrome Fertil Steril 89 2008 505 522
10. M.F. Costello, M. Chapman, and U. Conway A systematic review and meta-analysis of randomized controlled trials on metformin co-administration during gonadotrophin ovulation induction or IVF in women with polycystic ovary syndrome Hum Reprod 21 2006 1387 1399 (Pubitemid 44445013)
11. J.P. Baillargeon, J.E. Nestler, R.E.J. Ostlund, T. Apridonidze, and E. Diamanti-Kandarakis Greek hyperinsulinemic women with or without polycystic ovary syndrome display altered inositols metabolism Hum Reprod 23 2008 1439 1446 (Pubitemid 351770579)
12. J.P. Baillargeon, M.J. Iuorno, T. Apridonidze, and J.E. Nestler Uncoupling between insulin and release of a D-chiro-inositol-containing inositolphosphoglycan mediator of insulin action in obese women with polycystic ovary syndrome Metab Syndr Relat Disord 8 2010 127 136
13. K.I. Cheang, J.P. Baillargeon, P.A. Essah, R.E. Ostlund Jr., T. Apridonize, and L. Islam Insulin-stimulated release of D-chiro-inositol- containing inositolphosphoglycan mediator correlates with insulin sensitivity in women with polycystic ovary syndrome Metabolism 57 2008 1390 1397
14. J.E. Nestler, D.J. Jakubowicz, P. Reamer, R.D. Gunn, and G. Allan Ovulatory and metabolic effects of D-chiro-inositol in the polycystic ovary syndrome N Engl J Med 340 1999 1314 1320 (Pubitemid 29196593)
15. M.J. Iuorno, D.J. Jakubowicz, J.P. Baillargeon, P. Dillon, R.D. Gunn, and G. Allan Effects of D-chiro-inositol in lean women with the polycystic ovary syndrome Endocrinol Pract 8 2002 417 423 (Pubitemid 35423128)
16. S. Gerli, M. Mignosa, and G.C. Di Renzo Effects of inositol on ovarian function and metabolic factors in women with PCOS: a randomized double blind placebo-controlled trial Eur Rev Med Pharmacol Sci 7 2003 151 159 (Pubitemid 38659930)
17. A.D. Genazzani, C. Lanzoni, F. Ricchieri, and V.M. Jasonni Myo-inositol administration positively affects hyperinsulinemia and hormonal parameters in overweight patients with polycystic ovary syndrome Gynecol Endocrinol 24 2008 139 144 (Pubitemid 351365855)
18. E. Papaleo, V. Unfer, J.P. Baillargeon, L. De Santis, F. Fusi, and C. Brigante Myo-inositol in patients with polycystic ovary syndrome: a novel method for ovulation induction Gynecol Endocrinol 23 2007 700 703 (Pubitemid 350261211)
19. E. Papaleo, V. Unfer, J.P. Baillargeon, and T.T. Chiu Contribution of myo-inositol to reproduction Eur J Obstet Gynecol Reprod Biol 147 2009 120 123
20. S. Gerli, E. Papaleo, A. Ferrari, and G.C. Di Renzo Randomized, double blind placebo-controlled trial: effects of myo-inositol on ovarian function and metabolic factors in women with PCOS Eur Rev Med Pharmacol Sci 11 2007 347 354 (Pubitemid 350200349)
21. E. Raffone, P. Rizzo, and V. Benedetto Insulin sensitiser agents alone and in co-treatment with r-FSH for ovulation induction in PCOS women Gynecol Endocrinol 26 2010 275 280
22. D.R. Matthews, J.P. Hosker, A.S. Rudenski, B.A. Naylor, D.F. Treacher, and R.C. Turner Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man Diabetologia 28 1985 412 419 (Pubitemid 15018832)
23. R.S. Legro, H.X. Barnhart, W.D. Schlaff, B.R. Carr, M.P. Diamond, and S.A. Carson Clomiphene, metformin, or both for infertility in polycystic ovary syndrome N Engl J Med 356 2007 551 566 (Pubitemid 46220816)
24. T. Tang, J.M. Lord, R.J. Norman, E. Yasmin, and A.H. Balen Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility Cochrane Database Syst Rev 1 2010 CD003053